Table 3.
Major adverse events and postnatal complications
| Therapeutic hypothermia (n=25) |
Standard care (n=25) |
P value | |
| Major adverse events | |||
| Death or withdrawal of care during intervention | 2 (8) | 1 (4) | 0.55 |
| Major cardiac arrhythmia | 0 | 0 | – |
| Persistent hypotension | 0 | 0 | – |
| Prolonged coagulation time | 23 (92) | 19 (76) | 0.12 |
| Thrombocytopenia | 4 (16) | 2 (8) | 0.38 |
| Severe haemorrhage | 0 | 2 (8)* | 0.15 |
| PPHN | 0 | 0 | – |
| Culture-positive sepsis | 0 | 0 | – |
| Postnatal complications | |||
| Death or withdrawal of care after intervention | 0 | 4 (17)† | 0.04 |
| Clinical seizures | 20 (80) | 22 (88) | 0.44 |
| ≥2 anticonvulsants | 9 (36) | 12 (48) | 0.39 |
| Mechanical ventilation >24 hours | 2 (8) | 6 (24) | 0.12 |
| Inotropic support | 14 (56) | 17 (68) | 0.38 |
| Treated coagulopathy | 10 (40) | 8 (32) | 0.56 |
| Hypoglycaemia | 2 (8) | 1 (4) | 0.55 |
| Hyperglycaemia requiring insulin | 1 (4) | 1 (4) | – |
Data are n (%).
*Both were subgaleal bleed requiring packed cell transfusion.
†Denominator 24 due to one withdrawal of care during the intervention.
PPHN, persistent pulmonary hypertension of the newborn.